ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years
Ricardo A. Léon-Letelier
Matched on ORCID iD 0000-0001-7575-0453; OpenAlex author ID A5016092134. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 22
2023: 1 paper · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper
Papers 5
- KRAS-driven metabolic reprogramming of enhanced MFSD2A-mediated lysophosphatidylcholine scavenging promotes survival and progression of pancreatic ductal adeno… Co-author DOI 10.64898/2026.10.05.756824↗
- Integrated Metabolomics and Spatial Transcriptomics of Cystic Pancreatic Cancer Precursors Reveals Dysregulated Polyamine Metabolism as a Biomarker of Progress… Co-author DOI 10.1158/1078-0432.ccr-24-2931↗
- Contributions of the Microbiome-Derived Metabolome for Risk Assessment and Prognostication of Pancreatic Cancer. Co-author DOI 10.1093/clinchem/hvad186↗
- A Blood-based Metabolite Signature for Personalized Risk Assessment of Pancreatic Cancer. Co-author DOI 10.33696/cancerimmunol.6.095↗
- Integrated spatial transcriptomics and lipidomics of precursor lesions of pancreatic cancer identifies enrichment of long chain sulfatide biosynthesis as an ea… Co-author DOI 10.1101/2023.08.14.553002↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ehsan Irajizad · 5 shared papers, 2023–2026 · strength 0.94
- Paper A Blood-based Metabolite Signature for Personalized Risk Assessment of Pancreatic Cancer. DOI 10.33696/cancerimmunol.6.095↗
- Paper KRAS-driven metabolic reprogramming of enhanced MFSD2A-mediated lysophosphatidylcholine scavenging promotes survival an… DOI 10.64898/2026.10.05.756824↗
- Paper Integrated Metabolomics and Spatial Transcriptomics of Cystic Pancreatic Cancer Precursors Reveals Dysregulated Polyami… DOI 10.1158/1078-0432.ccr-24-2931↗
- Johannes Francois Fahrmann · 5 shared papers, 2023–2026 · strength 0.94
- Paper A Blood-based Metabolite Signature for Personalized Risk Assessment of Pancreatic Cancer. DOI 10.33696/cancerimmunol.6.095↗
- Paper KRAS-driven metabolic reprogramming of enhanced MFSD2A-mediated lysophosphatidylcholine scavenging promotes survival an… DOI 10.64898/2026.10.05.756824↗
- Paper Integrated Metabolomics and Spatial Transcriptomics of Cystic Pancreatic Cancer Precursors Reveals Dysregulated Polyami… DOI 10.1158/1078-0432.ccr-24-2931↗
- Anirban Maitra · 5 shared papers, 2023–2026 · strength 0.94
- Paper A Blood-based Metabolite Signature for Personalized Risk Assessment of Pancreatic Cancer. DOI 10.33696/cancerimmunol.6.095↗
- Paper KRAS-driven metabolic reprogramming of enhanced MFSD2A-mediated lysophosphatidylcholine scavenging promotes survival an… DOI 10.64898/2026.10.05.756824↗
- Paper Integrated Metabolomics and Spatial Transcriptomics of Cystic Pancreatic Cancer Precursors Reveals Dysregulated Polyami… DOI 10.1158/1078-0432.ccr-24-2931↗
- Jianjun Zhang · 4 shared papers, 2023–2025 · strength 0.73
- Paper A Blood-based Metabolite Signature for Personalized Risk Assessment of Pancreatic Cancer. DOI 10.33696/cancerimmunol.6.095↗
- Paper Integrated Metabolomics and Spatial Transcriptomics of Cystic Pancreatic Cancer Precursors Reveals Dysregulated Polyami… DOI 10.1158/1078-0432.ccr-24-2931↗
- Paper Contributions of the Microbiome-Derived Metabolome for Risk Assessment and Prognostication of Pancreatic Cancer. DOI 10.1093/clinchem/hvad186↗
- Christian Max Schmidt · 4 shared papers, 2023–2025 · strength 0.73
- Paper A Blood-based Metabolite Signature for Personalized Risk Assessment of Pancreatic Cancer. DOI 10.33696/cancerimmunol.6.095↗
- Paper Integrated Metabolomics and Spatial Transcriptomics of Cystic Pancreatic Cancer Precursors Reveals Dysregulated Polyami… DOI 10.1158/1078-0432.ccr-24-2931↗
- Paper Contributions of the Microbiome-Derived Metabolome for Risk Assessment and Prognostication of Pancreatic Cancer. DOI 10.1093/clinchem/hvad186↗
- Jody V. Vykoukal · 4 shared papers, 2023–2026 · strength 0.73
- Paper KRAS-driven metabolic reprogramming of enhanced MFSD2A-mediated lysophosphatidylcholine scavenging promotes survival an… DOI 10.64898/2026.10.05.756824↗
- Paper Integrated Metabolomics and Spatial Transcriptomics of Cystic Pancreatic Cancer Precursors Reveals Dysregulated Polyami… DOI 10.1158/1078-0432.ccr-24-2931↗
- Paper Contributions of the Microbiome-Derived Metabolome for Risk Assessment and Prognostication of Pancreatic Cancer. DOI 10.1093/clinchem/hvad186↗
- Samir Hanash · 4 shared papers, 2023–2026 · strength 0.73
- Paper KRAS-driven metabolic reprogramming of enhanced MFSD2A-mediated lysophosphatidylcholine scavenging promotes survival an… DOI 10.64898/2026.10.05.756824↗
- Paper Integrated Metabolomics and Spatial Transcriptomics of Cystic Pancreatic Cancer Precursors Reveals Dysregulated Polyami… DOI 10.1158/1078-0432.ccr-24-2931↗
- Paper Contributions of the Microbiome-Derived Metabolome for Risk Assessment and Prognostication of Pancreatic Cancer. DOI 10.1093/clinchem/hvad186↗
- Riccardo Ballarò · 3 shared papers, 2024–2026 · strength 0.62
- Paper A Blood-based Metabolite Signature for Personalized Risk Assessment of Pancreatic Cancer. DOI 10.33696/cancerimmunol.6.095↗
- Paper KRAS-driven metabolic reprogramming of enhanced MFSD2A-mediated lysophosphatidylcholine scavenging promotes survival an… DOI 10.64898/2026.10.05.756824↗
- Paper Integrated Metabolomics and Spatial Transcriptomics of Cystic Pancreatic Cancer Precursors Reveals Dysregulated Polyami… DOI 10.1158/1078-0432.ccr-24-2931↗
- Yihui Chen · 3 shared papers, 2023–2026 · strength 0.54
- Paper KRAS-driven metabolic reprogramming of enhanced MFSD2A-mediated lysophosphatidylcholine scavenging promotes survival an… DOI 10.64898/2026.10.05.756824↗
- Paper Integrated Metabolomics and Spatial Transcriptomics of Cystic Pancreatic Cancer Precursors Reveals Dysregulated Polyami… DOI 10.1158/1078-0432.ccr-24-2931↗
- Paper Integrated spatial transcriptomics and lipidomics of precursor lesions of pancreatic cancer identifies enrichment of lo… DOI 10.1101/2023.08.14.553002↗
- Michele Yip-Schneider · 3 shared papers, 2023–2025 · strength 0.52
- Paper Integrated Metabolomics and Spatial Transcriptomics of Cystic Pancreatic Cancer Precursors Reveals Dysregulated Polyami… DOI 10.1158/1078-0432.ccr-24-2931↗
- Paper Contributions of the Microbiome-Derived Metabolome for Risk Assessment and Prognostication of Pancreatic Cancer. DOI 10.1093/clinchem/hvad186↗
- Paper Integrated spatial transcriptomics and lipidomics of precursor lesions of pancreatic cancer identifies enrichment of lo… DOI 10.1101/2023.08.14.553002↗
- Benson Chellakkan Selvanesan · 1 shared paper, 2026 · strength 0.21
- LaNisha L. Patterson · 1 shared paper, 2026 · strength 0.21
- Vincent Bernard Pagan · 1 shared paper, 2026 · strength 0.21
- Brian Matthew Wolpin · 1 shared paper, 2026 · strength 0.21
- Eugene Jon Koay · 1 shared paper, 2026 · strength 0.21
- Florencia M. McAllister · 1 shared paper, 2026 · strength 0.21
- Fredrik I. Thege · 1 shared paper, 2023 · strength 0.13
- Jimin Min · 1 shared paper, 2023 · strength 0.13
- Robert A. Wolff · 1 shared paper, 2023 · strength 0.13
- Paola A. Guerrero · 1 shared paper, 2023 · strength 0.13
- Marta Sans · 1 shared paper, 2023 · strength 0.13
- Michael P. Kim · 1 shared paper, 2023 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.